Skip to content

Study for the usefulness of exercise by electrical muscle stimulation device in patients with fatty liver

Study for the usefulness of exercise by electrical muscle stimulation device in patients with fatty liver - Exercise by electrical muscle stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030656
Enrollment
6
Registered
2018-01-10
Start date
2018-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with fatty liver

Interventions

Exercise by EMS device for 12 weeks

Sponsors

Saitama Medical University
Lead Sponsor
Toray International, Inc.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient diagnosed as fatty liver by abdominal ultrasonography with no drinking history.

Exclusion criteria

Exclusion criteria: 1) Patients who can not affix the EMS device to their lower limbs 2) Pregnancy, nursing woman or possibly pregnant woman 3) Patients wearing implantable medical electrical equipment such as pacemakers 4) Patient wearing life support electrical equipment such as heart-lung machine 5) Patient wearing medical-type electrical equipment such as electrocardiograph 6) Patients with metal deposits on the body such as a tattoo 7) Patients with history of epilepsy or neurological disorder 8) Patients diagnosed with viral hepatitis 9) Patients diagnosed with autoimmune liver disease 10) Patients diagnosed with drug-induced liver injury 11) Patients with malignant tumors 12) Patients receiving medication to treat fatty liver 13) Patients who thought to be inappropriate to enter this study for some reasons by physician's judgments

Design outcomes

Primary

MeasureTime frame
Serological indicators (ALT, AST, GGT) and NAFLD scoring system in abdominal ultrasound at 12 weeks after initiation of EMS exercise

Countries

Japan

Contacts

Public ContactYoshihito UCHIDA

Saitama Medical University Department of Gastroenterology & Hepatology

y_uchida@saitama-med.ac.jp049-276-1198

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026